LMNA-NTRK1 fusion-positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report.

Sawada K, Watanabe R, Okamoto K, Kon M, Yonemura H, Nishimura Y, Hosoda S, Takahashi S, Nakamura T, Oda H, Miyagishima T

Open source

DOI: 10.1007/s13691-026-00909-8
Published: 2026 Oct
Container: International cancer conference journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13691-026-00909-8,
  title = {LMNA-NTRK1 fusion-positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report.},
  author = {Sawada K and Watanabe R and Okamoto K and Kon M and Yonemura H and Nishimura Y and Hosoda S and Takahashi S and Nakamura T and Oda H and Miyagishima T},
  year = {2026},
  journal = {International cancer conference journal},
  doi = {10.1007/s13691-026-00909-8},
  url = {https://doi.org/10.1007/s13691-026-00909-8}
}

RIS

TY  - JOUR
TI  - LMNA-NTRK1 fusion-positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report.
AU  - Sawada K
AU  - Watanabe R
AU  - Okamoto K
AU  - Kon M
AU  - Yonemura H
AU  - Nishimura Y
AU  - Hosoda S
AU  - Takahashi S
AU  - Nakamura T
AU  - Oda H
AU  - Miyagishima T
PY  - 2026
JO  - International cancer conference journal
DO  - 10.1007/s13691-026-00909-8
UR  - https://doi.org/10.1007/s13691-026-00909-8
ER  -

APA

K, S., R, W., K, O., M, K., H, Y., Y, N., S, H., S, T., T, N., H, O., & T, M. (2026). LMNA-NTRK1 fusion-positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report.. International cancer conference journal. https://doi.org/10.1007/s13691-026-00909-8

Source records

pubmed · retrieved 2026-09-25T12:25:33.028Z